ACE and atrial fibrillation: We hypothesized that this might be related to the renin- and angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and statins taken by AF patients, which could reduce vascular oxidative stress and have vasoprotective effects (Förstermann and Sessa, 2012).